Combined Electroacupuncture and Auricular Acupuncture for Persistent Insomnia

May 10, 2016 updated by: Dr. Chung Ka-Fai, The University of Hong Kong

Combined Electroacupuncture and Auricular Acupuncture for Persistent Insomnia: A Randomized Controlled Trial of Dose-Response Effect

This is a randomized controlled trial to evaluate the clinical efficacy of combined electro-acupuncture and auricular acupuncture for persistent Iinsomnia in the adult population in Hong Kong.

Study Overview

Detailed Description

Combined electro-acupuncture and auricular acupuncture is potential to be an alternative treatment for primary insomnia. The purpose of this study is to evaluate the clinical effectiveness of combined electroacupuncture and auricular acupuncture on persistent insomnia. This is a randomized double-blinded controlled trial. Patients will be randomly assigned to the electro-acupuncture group, the electro-acupuncture plus auricular acupuncture group or the waitlist controlled group. Patients will be put into groups and then compared.The chance of getting into each group is 3:3:1.

Study Type

Interventional

Enrollment (Actual)

224

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hong Kong, Hong Kong
        • Queen Mary Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 63 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Aged 18 years or above
  • Hong Kong residents
  • Ethnic Chinese
  • Meet the diagnosis criteria of presistent insomnia for at least 3 months according to Current Diagnostic and Statistical Manual of Mental Disorders (the proposed Fifth Edition)
  • Insomnia more than 3 nights per week for at least 3 months
  • Willing to give informed consent
  • Able to comply with trial protocol

Exclusion Criteria:

  • Have a Hamilton Depression Rating Scale scores above 18
  • Have sleep apnea or periodic limbs movement disorder detected by overnight polysomnography
  • Have suicidal risk as assessed by the Hamilton Depression Rating Scale suicidal risk item
  • Have current major depressive disorder, generalized anxiety disorders or panic disorder, manic or hypomanic episode, substance use disorders except caffeine and nicotine, organic mental disorder, schizophrenia or any other psychotic disorder
  • Receiving psychotropic drugs with dosage changes in the last 4 weeks prior to screening, baseline or during the study
  • Have valvular heart defects or bleeding disorders or were taking anticoagulant drugs
  • Are pregnant, breast-feeding, or woman of childbearing potential not using adequate contraception
  • Have any unstable psychiatric conditions or serious physical illnesses which are judged by the investigator to render unsuitable or unsafe
  • Have infection or abscess close to the site of selected acupoints and in the investigator's opinion inclusion is unsafe
  • Taking Chinese herbal medicine or over-the-counter drugs which are intending for insomnia within the last 2 weeks prior to baseline or during the study
  • Any acupuncture or auricular acupuncture treatment during the previous 6 months prior to baseline

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Acupuncture
Patients will be treated at bilateral Ear Shenmen, Sishencong EX-HN1, Anmian, Neiguan PC6, Shenmen HT7, Sanyinjiao SP6, and unilateral Yintang EX-HN3 and Baihui GV20. Acupuncture treatment will be performed by a registered Chinese medicine practitioner. "De qi"(an irradiating feeling considered to be indicative of effective needling) is achieved if possible. An electric-stimulator (ITO ES160, Japan) is connected to these needles to give an electric-stimulation in continuous wave, frequency of 4 Hz, 0.4 ms square wave pulses and constant current. Surgical tape or hair pin will be adhered to the needles.The needles will be left for 30 min and then removed. Acupuncture treatment will consist of three sessions per week for 3 consecutive weeks.
Acupuncture at bilateral Ear Shenmen, Sishencong EX-HN1 , Anmian , Neiguan PC6 , Shenmen HT7 , Sanyinjiao SP6 , and unilateral Yintang EX-HN3 and Baihui GV20. The needles will be left for 30 min and then removed. Acupuncture treatment will consist of three sessions per week for 3 consecutive weeks.
Other Names:
  • Electroacupuncture
Experimental: Acupuncture plus auricular acupuncture
Subjects will be treated with electroacupuncture plus auricular acupuncture for 3 weeks. The acupuncture regimen, is the same as in electroacupuncture group. In additional to electroacupuncture, subjects will receive auricular acupuncture using borneol. The following 6 ear acupoints points will be selected: Ear Shenmen, Heart, Kidney, Liver, Spleen, Occiput, and Subcortex. In each treatment borneol crystals will be attached to the left or right side of the ear in alternation with adhesive plaster in each acupuncture treatment visit. Subjects will be asked to press the borneol crystals lightly for five minutes in the morning, afternoon and evening everyday and reminded them to remove the plaster and borneol crystals after 48 hours. We will check for skin irritation at each treatment visit.

Acupuncture at bilateral Ear Shenmen, Sishencong EX-HN1 , Anmian , Neiguan PC6 , Shenmen HT7 , Sanyinjiao SP6 , and unilateral Yintang EX-HN3 and Baihui GV20. The needles will be left for 30 min and then removed. Acupuncture treatment will consist of three sessions per week for 3 consecutive weeks.

Aricular acupuncture at Ear Shenmen, Heart, Kidney, Liver, Spleen, Occiput, and Subcortex.In each treatment borneol crystals will be attached to the left or right side of the ear in alternation with adhesive plaster in each acupuncture treatment visit. Subjects will be asked to press the borneol crystals lightly for five minutes in the morning, afternoon and evening everyday and reminded them to remove the plaster and borneol crystals after 48 hours.

Other Names:
  • Acupuncture
  • Electroacupuncture
No Intervention: Waiting-list control
This group will receive no treatment. Subjects will be assessed at baseline and the 4th and 7th week; afterwards, they will be randomized to one of the other two groups in the ratio of 1:1.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes of sleep parameters by subjective measures using sleep log
Time Frame: Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment
We will measure sleep parameters (including sleep onset latency, sleep efficiency, total sleep time, times of wakening during sleep) by subjective measures using sleep log. The measure is a composite outcome measure consisting of multiple measures
Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of self-rated sleep quality score measured by Insomnia Severity Index (ISI) questionnaire
Time Frame: Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment
Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment
Change of self-rated sleep quality score measured by the Pittsburgh Sleep Quality Index (PSQI) questionnaire
Time Frame: Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment
Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment
Change of anxiety and depression states measured by Hospital Anxiety and Depression Scale (HADS)
Time Frame: Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment
Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment
Change of subjects' functioning regarding work/study, social life and family measured by Sheehan Disability Scale (SDS)
Time Frame: Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment
Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment
Change of subjects' self-rated fatigue score measured by Multidimensional Fatigue Inventory (MFI)
Time Frame: Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment
Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment
Change of subjects' likeliness of dozing measured by Epworth Sleepiness Scale (ESS)
Time Frame: Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment
Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment
Change of subjects' sleep-related cognition measured by Dysfunctional Beliefs and Attitudes about Sleep (DBAS)
Time Frame: Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment
Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment
Change of subjects' sleep inhibitory behaviors measured by Sleep Hygiene Practice Scale (SHPS)
Time Frame: Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment
Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment
Change of subjects' credibility to the treatment measured by Credibility of treatment rating scale
Time Frame: Second and the last time of the treatment; 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment
Second and the last time of the treatment; 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment
Change of sleep parameters (sleep onset latency, sleep efficiency, total sleep time, times of wakening during sleep) by objective measure - wrist actigraphy
Time Frame: Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment
Sleep parameters include sleep onset latency, sleep efficiency, total sleep time, times of wakening during sleep. The measure is a composite outcome measure consisting of multiple measures
Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment
Change of serious adverse events measured by Serious Adverse Event (SAE)
Time Frame: 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment
1-week posttreatment, 4-week posttreatment, and 13-week posttreatment
Change of potential adverse events related to acupuncture measured by Adverse Events Report Related to Acupuncture
Time Frame: 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment
1-week posttreatment, 4-week posttreatment, and 13-week posttreatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2012

Primary Completion (Actual)

May 1, 2015

Study Completion (Actual)

May 1, 2015

Study Registration Dates

First Submitted

June 20, 2013

First Submitted That Met QC Criteria

June 27, 2013

First Posted (Estimate)

July 2, 2013

Study Record Updates

Last Update Posted (Estimate)

May 12, 2016

Last Update Submitted That Met QC Criteria

May 10, 2016

Last Verified

May 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Insomnia

Clinical Trials on Acupuncture

3
Subscribe